National Immunization Schedule (NIS): Birth to 5 Years<\/strong><\/h2>\nHere is a detailed table of the recommended vaccination schedule<\/strong> as per the Ministry of Health & Family Welfare, Government of India (2025)<\/strong>:<\/p>\n\n
\n
\n\n\nAge<\/strong><\/th>\nVaccine<\/strong><\/th>\nRoute<\/strong><\/th>\nSite<\/strong><\/th>\n<\/tr>\n<\/thead>\n\n\nAt Birth<\/strong><\/td>\n– BCG (Bacillus Calmette-Guerin)
\n– OPV-0 (Oral Polio Vaccine)
\n– Hepatitis B-0<\/td>\n | IM, Oral<\/td>\n | Left arm, Mouth, Thigh<\/td>\n<\/tr>\n | \n6 Weeks<\/strong><\/td>\n– Pentavalent-1 (DPT + Hep B + Hib)
\n– OPV-1
\n– Rotavirus-1
\n– IPV-1 (Inactivated Polio Vaccine)
\n– PCV-1 (Pneumococcal)<\/td>\n | IM, Oral<\/td>\n | Thigh, Mouth<\/td>\n<\/tr>\n | \n10 Weeks<\/strong><\/td>\n– Pentavalent-2
\n– OPV-2
\n– Rotavirus-2<\/td>\n | IM, Oral<\/td>\n | Thigh, Mouth<\/td>\n<\/tr>\n | \n14 Weeks<\/strong><\/td>\n– Pentavalent-3
\n– OPV-3
\n– Rotavirus-3
\n– IPV-2
\n– PCV-2<\/td>\n | IM, Oral<\/td>\n | Thigh, Mouth<\/td>\n<\/tr>\n | \n9-12 Months<\/strong><\/td>\n– Measles-Rubella (MR-1)
\n– JE-1 (only in endemic districts)
\n– PCV Booster<\/td>\n | Subcutaneous, IM<\/td>\n | Arm, Thigh<\/td>\n<\/tr>\n | \n16-24 Months<\/strong><\/td>\n– MR-2
\n– DPT Booster-1
\n– OPV Booster
\n– JE-2 (if applicable)<\/td>\n | IM, Oral, SC<\/td>\n | Arm, Mouth<\/td>\n<\/tr>\n | \n5-6 Years<\/strong><\/td>\n| – DPT Booster-2<\/td>\n | IM<\/td>\n | Arm<\/td>\n<\/tr>\n | \n10 Years<\/strong><\/td>\n| – Td (Tetanus and Diphtheria)<\/td>\n | IM<\/td>\n | Arm<\/td>\n<\/tr>\n | \n16 Years<\/strong><\/td>\n| – Td<\/td>\n | IM<\/td>\n | Arm<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\nExplanation of Key Vaccines<\/strong><\/h2>\n1. BCG (Bacillus Calmette-Guerin)<\/strong><\/h3>\n\n- \n
Disease Prevented:<\/strong> Tuberculosis (TB)<\/p>\n<\/li>\n- \n
Given at:<\/strong> Birth (within 24 hours)<\/p>\n<\/li>\n- \n
Dose:<\/strong> 0.1 ml intradermally<\/p>\n<\/li>\n- \n
Site:<\/strong> Left upper arm<\/p>\n<\/li>\n- \n
Notes:<\/strong> A small scar usually forms at the injection site.<\/p>\n<\/li>\n<\/ul>\n2. OPV (Oral Polio Vaccine)<\/strong><\/h3>\n\n- \n
Disease Prevented:<\/strong> Poliomyelitis<\/p>\n<\/li>\n- \n
Given at:<\/strong> Birth, 6, 10, 14 weeks, 16-24 months<\/p>\n<\/li>\n- \n
Dose:<\/strong> 2 oral drops<\/p>\n<\/li>\n- \n
Route:<\/strong> Oral<\/p>\n<\/li>\n- \n
Notes:<\/strong> Part of India\u2019s effort to remain polio-free.<\/p>\n<\/li>\n<\/ul>\n3. Hepatitis B<\/strong><\/h3>\n\n- \n
Disease Prevented:<\/strong> Hepatitis B virus infection<\/p>\n<\/li>\n- \n
Given at:<\/strong> Birth, 6, 10, 14 weeks (in Pentavalent)<\/p>\n<\/li>\n- \n
Dose:<\/strong> 0.5 ml<\/p>\n<\/li>\n- \n
Route:<\/strong> Intramuscular<\/p>\n<\/li>\n- \n
Site:<\/strong> Anterolateral thigh<\/p>\n<\/li>\n<\/ul>\n4. Pentavalent Vaccine<\/strong><\/h3>\n\n- \n
Diseases Prevented:<\/strong> Diphtheria, Pertussis, Tetanus, Hepatitis B, Hib<\/p>\n<\/li>\n- \n
Given at:<\/strong> 6, 10, and 14 weeks<\/p>\n<\/li>\n- \n
Dose:<\/strong> 0.5 ml<\/p>\n<\/li>\n- \n
Route:<\/strong> IM<\/p>\n<\/li>\n- \n
Notes:<\/strong> Replaced DPT, Hep B, and Hib monovalent vaccines.<\/p>\n<\/li>\n<\/ul>\n5. IPV (Inactivated Polio Vaccine)<\/strong><\/h3>\n\n- \n
Disease Prevented:<\/strong> Polio<\/p>\n<\/li>\n- \n
Given at:<\/strong> 6 and 14 weeks<\/p>\n<\/li>\n- \n
Route:<\/strong> IM<\/p>\n<\/li>\n- \n
Notes:<\/strong> Administered along with OPV for better protection.<\/p>\n<\/li>\n<\/ul>\n6. Rotavirus Vaccine<\/strong><\/h3>\n\n- \n
Disease Prevented:<\/strong> Diarrhea due to Rotavirus<\/p>\n<\/li>\n- \n
Given at:<\/strong> 6, 10, and 14 weeks<\/p>\n<\/li>\n- \n
Route:<\/strong> Oral<\/p>\n<\/li>\n- \n
Dose:<\/strong> 5 drops (varies by brand)<\/p>\n<\/li>\n- \n
Notes:<\/strong> Reduces infant mortality due to diarrhea.<\/p>\n<\/li>\n<\/ul>\n7. PCV (Pneumococcal Conjugate Vaccine)<\/strong><\/h3>\n\n- \n
Disease Prevented:<\/strong> Pneumonia, meningitis, sepsis<\/p>\n<\/li>\n- \n
Given at:<\/strong> 6 and 14 weeks, booster at 9-12 months<\/p>\n<\/li>\n- \n
Route:<\/strong> IM<\/p>\n<\/li>\n- \n
Notes:<\/strong> Rolled out under UIP in high-burden districts first.<\/p>\n<\/li>\n<\/ul>\n8. Measles-Rubella (MR) Vaccine<\/strong><\/h3>\n\n- \n
Disease Prevented:<\/strong> Measles and Rubella<\/p>\n<\/li>\n- \n
Given at:<\/strong> 9-12 months, 16-24 months<\/p>\n<\/li>\n- \n
Route:<\/strong> Subcutaneous<\/p>\n<\/li>\n- \n
Notes:<\/strong> MR campaign launched nationwide in 2017.<\/p>\n<\/li>\n<\/ul>\n9. DPT Booster<\/strong><\/h3>\n\n- \n
Disease Prevented:<\/strong> Diphtheria, Pertussis, Tetanus<\/p>\n<\/li>\n- \n
Given at:<\/strong> 16-24 months and 5-6 years<\/p>\n<\/li>\n- \n
Route:<\/strong> IM<\/p>\n<\/li>\n- \n
Dose:<\/strong> 0.5 ml<\/p>\n<\/li>\n<\/ul>\n10. Japanese Encephalitis (JE)<\/strong><\/h3>\n | | | | | | | | | | | | | |